Suppliers / Newland Pharmaceutical

Newland Pharmaceutical

Updated 9 July 2026

Newland Pharmaceutical is an API manufacturer. It holds 2 active US drug master files across a filed portfolio of 2 molecules.

2
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Fondaparinux US FDA 1
Moxifloxacin US FDA 1

Also appears on these molecule pages

Moxifloxacin API

Comparing suppliers?

Choose your molecules and target markets. Newland Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability